Literature DB >> 31722906

Cannabis legislation provides an opportunity to strengthen primary care substance use counseling.

Yezarni Wynn1, Sheryl Spithoff2, Daniel Z Buchman3.   

Abstract

Year:  2019        PMID: 31722906      PMCID: PMC6853362     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  6 in total

1.  Posttraumatic stress disorder and substance use disorder in adolescent bipolar disorder.

Authors:  Petra H Steinbuchel; Timothy E Wilens; Joel J Adamson; Stephanie Sgambati
Journal:  Bipolar Disord       Date:  2009-03       Impact factor: 6.744

Review 2.  Treatment of Cannabis Use Disorder: Current Science and Future Outlook.

Authors:  Brian J Sherman; Aimee L McRae-Clark
Journal:  Pharmacotherapy       Date:  2016-05       Impact factor: 4.705

Review 3.  Adverse health effects of marijuana use.

Authors:  Nora D Volkow; Ruben D Baler; Wilson M Compton; Susan R B Weiss
Journal:  N Engl J Med       Date:  2014-06-05       Impact factor: 91.245

Review 4.  Harm reduction therapy: a practice-friendly review of research.

Authors:  Diane E Logan; G Alan Marlatt
Journal:  J Clin Psychol       Date:  2010-02

Review 5.  Motivational Interviewing for adolescent substance use: a review of the literature.

Authors:  Elizabeth Barnett; Steve Sussman; Caitlin Smith; Louise A Rohrbach; Donna Spruijt-Metz
Journal:  Addict Behav       Date:  2012-07-11       Impact factor: 3.913

Review 6.  Cannabis Use during Adolescent Development: Susceptibility to Psychiatric Illness.

Authors:  Benjamin Chadwick; Michael L Miller; Yasmin L Hurd
Journal:  Front Psychiatry       Date:  2013-10-14       Impact factor: 4.157

  6 in total
  1 in total

1.  Protocol for a feasibility study investigating the UCalgary's Cannabis Café: education and harm reduction initiative for postsecondary students.

Authors:  Joel Mader; Jacqueline M Smith; Jennifer Smith; Darren Robert Christensen
Journal:  BMJ Open       Date:  2020-02-12       Impact factor: 2.692

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.